Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Prevention of Chronic Postsurgical Pain in Adolescents with Scoliosis
NCT03867240Phase 3Withdrawn
- Sponsor
- Emory University
- Start
- Jun 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic postsurgical pain (CPSP) comparing Gabapentin with Placebo (2 arms). Primary endpoints: Numeric Rating Scale for Pain Intensity at 6 months and Functional Disability Inventory at 6 months. Planned start Jun 2019; status: withdrawn.
02
Drugs
gabapentin
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT03867240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03867240.